Atlas Trials

Tissue Analysis After Tumor Ablation for Liver Metastases Leading to Immediate Retreatment

Clinical trial NCT04143516 · RECRUITING

Trial details

NCT number
NCT04143516
Sponsor
Memorial Sloan Kettering Cancer Center
Status
RECRUITING
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Liver Metastases
Start date
2019-10-25
Primary completion
2026-10-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.